US Stock MarketDetailed Quotes

TSBX Turnstone Biologics

Watchlist

2.710
+0.110+4.23%

Close May 28 16:00 ET

2.670
-0.040-1.48%

Post 17:42 ET

62.68MMarket Cap-836P/E (TTM)

Turnstone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-1.69%-17.46M

6.91%-66.15M

20.52%-15.5M

-56.39%-18.79M

36.36%-14.69M

-4.35%-17.17M

-55.74%-71.06M

-19.51M

-12.01M

-23.09M

Net income from continuing operations

-28,966.18%-19.63M

-79.02%-55.2M

-20.36%-16.45M

-7.23%-17.32M

-285.34%-21.5M

100.54%68K

-192.68%-30.83M

---13.67M

---16.15M

--11.6M

Operating gains losses

47.37%-20K

--324K

--0

--338K

--24K

---38K

----

Depreciation and amortization

-28.21%509K

-28.27%2.8M

-44.39%659K

-34.76%700K

-21.67%730K

-0.28%709K

180.65%3.9M

--1.19M

--1.07M

--932K

Other non cash items

-208.98%-791K

-2,001.02%-2.06M

-292.98%-951K

-1,900.00%-640K

-416.42%-212K

-334.86%-256K

-108.42%-98K

---242K

---32K

--67K

Change In working capital

107.12%1.37M

69.08%-17.92M

102.23%211K

-5.43%-3.8M

112.67%4.93M

-222.78%-19.26M

32.41%-57.97M

---9.48M

---3.61M

---38.91M

-Change in receivables

-95.43%194K

523.94%8.53M

100.54%23K

-97.20%33K

1,656.43%4.23M

396.49%4.25M

14.92%-2.01M

---4.29M

--1.18M

--241K

-Change in prepaid assets

243.75%115K

316.24%426K

231.39%2.72M

-179.93%-2.95M

256.41%732K

94.05%-80K

92.62%-197K

---2.07M

--3.69M

---468K

-Change in payables and accrued expense

125.64%676K

-207.13%-4.52M

-204.24%-1.52M

68.17%-784K

6,966.67%424K

-452.83%-2.64M

-179.65%-1.47M

--1.46M

---2.46M

--6K

-Change in other current assets

336.81%431K

-373.72%-1.5M

-152.21%-1M

-81.54%125K

---440K

---182K

--548K

--1.92M

--677K

----

-Change in other current liabilities

96.62%-44K

10.37%-1.56M

98.27%-6K

74.53%-231K

94.75%-18K

-842.03%-1.3M

-175.83%-1.74M

---347K

---907K

---343K

-Change in other working capital

----

63.64%-19.31M

--0

-297.08%-19.31M

35.20%-53.1M

---6.16M

---5.78M

---36.3M

Cash from discontinued investing activities

Operating cash flow

-1.69%-17.46M

6.91%-66.15M

20.52%-15.5M

-56.39%-18.79M

36.36%-14.69M

-4.35%-17.17M

-55.74%-71.06M

---19.51M

---12.01M

---23.09M

Investing cash flow

Cash flow from continuing investing activities

-14.58%14.1M

-88.14%-28.09M

-191.47%-5.31M

-146.46%-42.26M

203.80%2.98M

2,398.05%16.5M

-346.00%-14.93M

5.8M

-17.15M

-2.87M

Net PPE purchase and sale

80.80%-144K

84.58%-797K

366.67%272K

88.21%-272K

97.81%-47K

-22.35%-750K

-51.79%-5.17M

---102K

---2.31M

---2.15M

Net investment purchase and sale

-17.46%14.24M

-179.61%-27.3M

-194.49%-5.58M

-182.96%-41.99M

520.31%3.02M

16,528.57%17.25M

-16,931.03%-9.76M

--5.9M

---14.84M

---719K

Cash from discontinued investing activities

Investing cash flow

-14.58%14.1M

-88.14%-28.09M

-191.47%-5.31M

-146.46%-42.26M

203.80%2.98M

2,398.05%16.5M

-346.00%-14.93M

--5.8M

---17.15M

---2.87M

Financing cash flow

Cash flow from continuing financing activities

3,000.83%77.05M

-3,480.00%-169K

2,885.34%78.3M

-290.00%-266K

-8,250.00%-815K

-103.32%-2.66M

-2.81M

140K

Net common stock issuance

----

--77.84M

---179K

----

--0

----

Proceeds from stock option exercised by employees

--0

-33.12%105K

100.00%10K

350.00%9K

-97.86%3K

730.00%83K

-53.69%157K

--5K

--2K

--140K

Net other financing activities

----

68.08%-898K

--0

--269K

---269K

---898K

---2.81M

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

3,000.83%77.05M

-3,480.00%-169K

2,885.34%78.3M

-290.00%-266K

-8,250.00%-815K

-103.32%-2.66M

--5K

---2.81M

--140K

Net cash flow

Beginning cash position

-48.98%17.91M

-71.63%35.11M

-20.33%38.89M

-73.21%21.65M

-68.45%33.63M

-71.63%35.11M

33.39%123.76M

--48.82M

--80.79M

--106.6M

Current changes in cash

-126.60%-3.37M

80.60%-17.2M

-53.09%-20.98M

153.94%17.25M

53.58%-11.98M

91.35%-1.49M

-386.18%-88.65M

---13.7M

---31.97M

---25.81M

End cash Position

-56.74%14.55M

-48.98%17.91M

-20.33%38.89M

-73.21%21.65M

-68.45%33.63M

-71.63%35.11M

--35.11M

--48.82M

--80.79M

Free cash flow

2.47%-17.6M

11.58%-67.4M

20.94%-15.5M

-32.99%-19.05M

41.34%-14.8M

-5.75%-18.05M

-55.46%-76.23M

---19.61M

---14.32M

---25.23M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-1.69%-17.46M	6.91%-66.15M	20.52%-15.5M	-56.39%-18.79M	36.36%-14.69M	-4.35%-17.17M	-55.74%-71.06M	-19.51M	-12.01M	-23.09M
Net income from continuing operations	-28,966.18%-19.63M	-79.02%-55.2M	-20.36%-16.45M	-7.23%-17.32M	-285.34%-21.5M	100.54%68K	-192.68%-30.83M	---13.67M	---16.15M	--11.6M
Operating gains losses	47.37%-20K	--324K	--0	--338K	--24K	---38K	----	----	----	----
Depreciation and amortization	-28.21%509K	-28.27%2.8M	-44.39%659K	-34.76%700K	-21.67%730K	-0.28%709K	180.65%3.9M	--1.19M	--1.07M	--932K
Other non cash items	-208.98%-791K	-2,001.02%-2.06M	-292.98%-951K	-1,900.00%-640K	-416.42%-212K	-334.86%-256K	-108.42%-98K	---242K	---32K	--67K
Change In working capital	107.12%1.37M	69.08%-17.92M	102.23%211K	-5.43%-3.8M	112.67%4.93M	-222.78%-19.26M	32.41%-57.97M	---9.48M	---3.61M	---38.91M
-Change in receivables	-95.43%194K	523.94%8.53M	100.54%23K	-97.20%33K	1,656.43%4.23M	396.49%4.25M	14.92%-2.01M	---4.29M	--1.18M	--241K
-Change in prepaid assets	243.75%115K	316.24%426K	231.39%2.72M	-179.93%-2.95M	256.41%732K	94.05%-80K	92.62%-197K	---2.07M	--3.69M	---468K
-Change in payables and accrued expense	125.64%676K	-207.13%-4.52M	-204.24%-1.52M	68.17%-784K	6,966.67%424K	-452.83%-2.64M	-179.65%-1.47M	--1.46M	---2.46M	--6K
-Change in other current assets	336.81%431K	-373.72%-1.5M	-152.21%-1M	-81.54%125K	---440K	---182K	--548K	--1.92M	--677K	----
-Change in other current liabilities	96.62%-44K	10.37%-1.56M	98.27%-6K	74.53%-231K	94.75%-18K	-842.03%-1.3M	-175.83%-1.74M	---347K	---907K	---343K
-Change in other working capital	----	63.64%-19.31M	--0	--0	--0	-297.08%-19.31M	35.20%-53.1M	---6.16M	---5.78M	---36.3M
Cash from discontinued investing activities
Operating cash flow	-1.69%-17.46M	6.91%-66.15M	20.52%-15.5M	-56.39%-18.79M	36.36%-14.69M	-4.35%-17.17M	-55.74%-71.06M	---19.51M	---12.01M	---23.09M
Investing cash flow
Cash flow from continuing investing activities	-14.58%14.1M	-88.14%-28.09M	-191.47%-5.31M	-146.46%-42.26M	203.80%2.98M	2,398.05%16.5M	-346.00%-14.93M	5.8M	-17.15M	-2.87M
Net PPE purchase and sale	80.80%-144K	84.58%-797K	366.67%272K	88.21%-272K	97.81%-47K	-22.35%-750K	-51.79%-5.17M	---102K	---2.31M	---2.15M
Net investment purchase and sale	-17.46%14.24M	-179.61%-27.3M	-194.49%-5.58M	-182.96%-41.99M	520.31%3.02M	16,528.57%17.25M	-16,931.03%-9.76M	--5.9M	---14.84M	---719K
Cash from discontinued investing activities
Investing cash flow	-14.58%14.1M	-88.14%-28.09M	-191.47%-5.31M	-146.46%-42.26M	203.80%2.98M	2,398.05%16.5M	-346.00%-14.93M	--5.8M	---17.15M	---2.87M
Financing cash flow
Cash flow from continuing financing activities	0	3,000.83%77.05M	-3,480.00%-169K	2,885.34%78.3M	-290.00%-266K	-8,250.00%-815K	-103.32%-2.66M	5K	-2.81M	140K
Net common stock issuance	----	--77.84M	---179K	----	----	----	--0	--0	----	----
Proceeds from stock option exercised by employees	--0	-33.12%105K	100.00%10K	350.00%9K	-97.86%3K	730.00%83K	-53.69%157K	--5K	--2K	--140K
Net other financing activities	----	68.08%-898K	--0	--269K	---269K	---898K	---2.81M	--0	----	----
Cash from discontinued financing activities
Financing cash flow	--0	3,000.83%77.05M	-3,480.00%-169K	2,885.34%78.3M	-290.00%-266K	-8,250.00%-815K	-103.32%-2.66M	--5K	---2.81M	--140K
Net cash flow
Beginning cash position	-48.98%17.91M	-71.63%35.11M	-20.33%38.89M	-73.21%21.65M	-68.45%33.63M	-71.63%35.11M	33.39%123.76M	--48.82M	--80.79M	--106.6M
Current changes in cash	-126.60%-3.37M	80.60%-17.2M	-53.09%-20.98M	153.94%17.25M	53.58%-11.98M	91.35%-1.49M	-386.18%-88.65M	---13.7M	---31.97M	---25.81M
End cash Position	-56.74%14.55M	-48.98%17.91M	-48.98%17.91M	-20.33%38.89M	-73.21%21.65M	-68.45%33.63M	-71.63%35.11M	--35.11M	--48.82M	--80.79M
Free cash flow	2.47%-17.6M	11.58%-67.4M	20.94%-15.5M	-32.99%-19.05M	41.34%-14.8M	-5.75%-18.05M	-55.46%-76.23M	---19.61M	---14.32M	---25.23M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall